Key result
This review discusses current management strategies, contemporary issues, and future goals for catheter ablation therapies in supraventricular tachycardia.
This review summarizes contemporary management strategies, physiology, ablation approaches, outcomes, and complications for catheter ablation of supraventricular tachycardias.
Answers are grounded in this paper and cite their sources.
May inform evolving SVT ablation strategies; leaves open optimization of safety and efficiency in complex cases.
The treatment of cardiac arrhythmias has evolved significantly over the last 30 years. Understanding of arrhythmia mechanisms has led to pharmacologic therapies, surgical interventions and the widely used percutaneous catheter ablation techniques. The focus of this review is centered on the current catheter ablation therapies available for supraventricular tachycardia. We will discuss current management strategies including challenges when considering catheter ablation therapy for management of supraventricular tachycardias: atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia utilizing an accessory pathway, atrial tachycardia and atrial flutter. Selected contemporary issues related to supraventricular tachycardia physiology, ablation approaches and ablation outcomes and complications will be discussed. Future goals for electrophysiologists are to continue to improve procedural safety and efficiency, while maintaining the impressive success rates that have been achieved.
No takes yet. Share an insight, caveat, or question.
Giedrimas et al. (2013) conducted a review in Supraventricular tachycardia. Catheter ablation was evaluated. This review discusses current management strategies, contemporary issues, and future goals for catheter ablation therapies in supraventricular tachycardia.
Synapse has enriched 10 related papers. Consider them for comparative context: